Literature DB >> 11401958

Characterization of Haemophilus ducreyi-specific T-cell lines from lesions of experimentally infected human subjects.

V Gelfanova1, T L Humphreys, S M Spinola.   

Abstract

Haemophilus ducreyi is the etiologic agent of chancroid, a sexually transmitted genital ulcer disease that facilitates the transmission of human immunodeficiency virus. In the human model of infection, the histopathology of infected sites in part resembles a delayed-type hypersensitivity (DTH) response. In this study, T cells were isolated from skin biopsy specimens obtained from 24 subjects who were infected for 7 to 14 days. One clone and 12 lines that responded to H. ducreyi antigens were obtained from 12 of the subjects. Fluorescence-activated cell sorter analysis showed that the antigen-responsive lines and clone were predominantly CD3(+) and CD4(+). The lines and clone responded to H. ducreyi antigen in a dose-dependent manner and produced gamma interferon (IFN-gamma) alone or IFN-gamma and interleukin-10 (IL-10) but no IL-4 or IL-5 in response to H. ducreyi. Proliferation of T cells was dependent on the presence of autologous antigen-presenting cells. The lines showed little response to antigens prepared from other members of the Pasteurellaceae and responded to different fractions of H. ducreyi separated by preparative sodium dodecyl sulfate-polyacrylamide gel electrophoresis. We conclude that T cells that recognize H. ducreyi antigens are recruited to sites experimentally infected with the organism. The lack of cross-reactivity to the Pasteurellaceae and the response of the lines to different antigen fractions suggest that subjects are sensitized to H. ducreyi during the course of infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11401958      PMCID: PMC98455          DOI: 10.1128/IAI.69.7.4224-4231.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  55 in total

1.  A pilus-deficient mutant of Haemophilus ducreyi is virulent in the human model of experimental infection.

Authors:  J A Al-Tawfiq; M E Bauer; K R Fortney; B P Katz; A F Hood; M Ketterer; M A Apicella; S M Spinola
Journal:  J Infect Dis       Date:  2000-03       Impact factor: 5.226

2.  Summary of Notifiable Diseases, United States, 1998.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1999-12-31       Impact factor: 17.586

3.  Human immunodeficiency virus infection and genital ulcer disease in South Africa: the herpetic connection.

Authors:  C Y Chen; R C Ballard; C M Beck-Sague; Y Dangor; F Radebe; S Schmid; J B Weiss; V Tshabalala; G Fehler; Y Htun; S A Morse
Journal:  Sex Transm Dis       Date:  2000-01       Impact factor: 2.830

4.  Etiology of genital ulcer disease in Dakar, Senegal, and comparison of PCR and serologic assays for detection of Haemophilus ducreyi.

Authors:  P A Totten; J M Kuypers; C Y Chen; M J Alfa; L M Parsons; S M Dutro; S A Morse; N B Kiviat
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

5.  Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products.

Authors:  E Lien; T J Sellati; A Yoshimura; T H Flo; G Rawadi; R W Finberg; J D Carroll; T Espevik; R R Ingalls; J D Radolf; D T Golenbock
Journal:  J Biol Chem       Date:  1999-11-19       Impact factor: 5.157

6.  Expression of sialylated or paragloboside-like lipooligosaccharides are not required for pustule formation by Haemophilus ducreyi in human volunteers.

Authors:  R S Young; K Fortney; J C Haley; A F Hood; A A Campagnari; J Wang; J A Bozue; R S Munson; S M Spinola
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

7.  An isogenic hemoglobin receptor-deficient mutant of Haemophilus ducreyi is attenuated in the human model of experimental infection.

Authors:  J A Al-Tawfiq; K R Fortney; B P Katz; A F Hood; C Elkins; S M Spinola
Journal:  J Infect Dis       Date:  2000-03       Impact factor: 5.226

8.  Localization of Haemophilus ducreyi at the pustular stage of disease in the human model of infection.

Authors:  M E Bauer; S M Spinola
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

9.  Direct recovery of herpes simplex virus (HSV)-specific T lymphocyte clones from recurrent genital HSV-2 lesions.

Authors:  D M Koelle; H Abbo; A Peck; K Ziegweid; L Corey
Journal:  J Infect Dis       Date:  1994-05       Impact factor: 5.226

10.  Cytolethal distending toxin of Haemophilus ducreyi induces apoptotic death of Jurkat T cells.

Authors:  V Gelfanova; E J Hansen; S M Spinola
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

View more
  12 in total

Review 1.  Immunopathogenesis of Haemophilus ducreyi infection (chancroid).

Authors:  Stanley M Spinola; Margaret E Bauer; Robert S Munson
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

2.  Differences in host susceptibility to disease progression in the human challenge model of Haemophilus ducreyi infection.

Authors:  Stanley M Spinola; Cliffton T H Bong; Andrew L Faber; Kate R Fortney; Stacy L Bennett; Carisa A Townsend; Beth E Zwickl; Steven D Billings; Tricia L Humphreys; Margaret E Bauer; Barry P Katz
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

3.  Role played by CD4+FOXP3+ regulatory T Cells in suppression of host responses to Haemophilus ducreyi during experimental infection of human volunteers.

Authors:  Wei Li; Klara Tenner-Racz; Paul Racz; Diane M Janowicz; Kate R Fortney; Barry P Katz; Stanley M Spinola
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

4.  Haemophilus ducreyi-induced interleukin-10 promotes a mixed M1 and M2 activation program in human macrophages.

Authors:  Wei Li; Barry P Katz; Stanley M Spinola
Journal:  Infect Immun       Date:  2012-10-01       Impact factor: 3.441

5.  Trafficking pathways and characterization of CD4 and CD8 cells recruited to the skin of humans experimentally infected with Haemophilus ducreyi.

Authors:  Tricia L Humphreys; Lee Ann Baldridge; Steven D Billings; James J Campbell; Stanley M Spinola
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

6.  Dysregulated immune profiles for skin and dendritic cells are associated with increased host susceptibility to Haemophilus ducreyi infection in human volunteers.

Authors:  Tricia L Humphreys; Lang Li; Xiaoman Li; Diane M Janowicz; Kate R Fortney; Qianqian Zhao; Wei Li; Jeanette McClintick; Barry P Katz; David S Wilkes; Howard J Edenberg; Stanley M Spinola
Journal:  Infect Immun       Date:  2007-09-24       Impact factor: 3.441

7.  Haemophilus ducreyi partially activates human myeloid dendritic cells.

Authors:  Keith E Banks; Tricia L Humphreys; Wei Li; Barry P Katz; David S Wilkes; Stanley M Spinola
Journal:  Infect Immun       Date:  2007-10-08       Impact factor: 3.441

8.  A humoral immune response confers protection against Haemophilus ducreyi infection.

Authors:  Leah E Cole; Kristen L Toffer; Robert A Fulcher; Lani R San Mateo; Paul E Orndorff; Thomas H Kawula
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

9.  Experimental infection of human volunteers with Haemophilus ducreyi: fifteen years of clinical data and experience.

Authors:  Diane M Janowicz; Susan Ofner; Barry P Katz; Stanley M Spinola
Journal:  J Infect Dis       Date:  2009-06-01       Impact factor: 5.226

10.  Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA protects against infection in the swine model of chancroid.

Authors:  Galyna Afonina; Isabelle Leduc; Igor Nepluev; Chrystina Jeter; Patty Routh; Glen Almond; Paul E Orndorff; Marcia Hobbs; Christopher Elkins
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.